SCM
CVAC

Shelton Capital Management’s CureVac CVAC Stock Holding History

Shelton Capital Management’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-24,000
Closed -$1.76M – 818
2021
Q2 		$1.76M Hold
24,000
– – 0.07% 237
2021
Q1 		$2.19M Hold
24,000
– – 0.08% 229
2020
Q4 		$1.95M Buy
24,000
+13,600
+131% +$1.04M 0.09% 206
2020
Q3 		$484K Buy
+10,400
New +$580K 0.02% 440

Other funds holding CVAC

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Shelton Capital Management's CVAC Position: Q3 2021 in Review

Shelton Capital Management sold out of CureVac (CVAC) in Q3 2021, closing a stake of 24,000 shares — an estimated $1.76M sold.

Shelton Capital Management first reported a position in CVAC in Q3 2020 and held it in 4 quarters. The position peaked at $2.19M in Q1 2021. 111 funds tracked by Wall St. Rank hold CVAC as of Q3 2021.

  • Shelton Capital Management reported no remaining CureVac position as of Q3 2021 after selling out during the quarter.
  • Shelton Capital Management sold 24,000 CureVac shares in Q3 2021, an estimated $1.76M.
  • Shelton Capital Management first reported a position in CureVac in Q3 2020 and held it in 4 quarters.
  • Shelton Capital Management's CureVac position peaked at $2.19M in Q1 2021.
  • 111 funds tracked by Wall St. Rank held CureVac as of Q3 2021.

Based on Shelton Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.